{"id":"W2141787758","doi":"10.1158/1535-7163.targ-09-b54","title":"Abstract B54: A phase 1 study to assess the safety, tolerability and pharmacokinetics of the ErbB-family inhibitor ARRY-334543 in patients with advanced solid tumors","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Juravinski Cancer Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Tolerability; Cmax; Capsule; Adverse effect; Pharmacology; Internal medicine; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001153271,0.001389631,0.002058988,0.0004208002,0.0004233223,0.0007819471,0.0007269879,0.001005589,0.005724816],"category_scores_gemma":[0.0007272322,0.0006382674,0.0009665816,0.0003686726,0.0005843839,0.0007124685,0.0003311741,0.002969637,0.001714353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008064282,"about_ca_system_score_gemma":0.001497951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001109856,"about_ca_topic_score_gemma":0.001972404,"domain_scores_codex":[0.9996363,0.0001604712,0.00002171287,0.0000718643,0.00004146062,0.00006819175],"domain_scores_gemma":[0.9994761,0.00007595545,0.0001003752,0.00004746381,0.00004497256,0.0002552543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5508303,0.09444934,0.01321054,0.001379378,0.001319967,0.0007392884,0.0003930036,0.003033436,0.2022569,0.0002877681,0.007856268,0.1242438],"study_design_scores_gemma":[0.2614963,0.7081805,0.01882511,0.00003882733,0.0003776939,0.0005867479,0.00006165242,0.001200039,0.005486629,0.0001237665,0.003584572,0.00003821265],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935141,0.001340484,0.0004585818,0.000300033,0.00006950226,0.001770621,0.001265383,0.0001064376,0.00117487],"genre_scores_gemma":[0.9863873,0.00161517,0.002118757,0.0008478624,0.0001197529,0.002432027,0.002843172,0.00005414122,0.003581906],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005724816,"threshold_uncertainty_score":0.01915145,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02731476882234154,"score_gpt":0.3634590329814251,"score_spread":0.3361442641590836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}